Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This collaboration aims to promote joint research, education, and innovation by combining allopathic medical science with ancient Ayurvedic knowledge to offer comprehensive and effective healthcare solutions.

The MoU was signed in the presence of AIIMS Bhopal’s Executive Director, Prof. (Dr.) Ajai Singh, and Patanjali Research Institute’s Chief Scientist, Dr. Anurag Varshney. The partnership will focus on collaborative research in critical areas such as fatty liver disease, allergies, lifestyle-related disorders, liver ailments, respiratory issues, kidney diseases, and neurological disorders. A key point of discussion during the event was the clinical controlled trials of Patanjali’s evidence-based Ayurvedic medicines, Livogrit and Bronchom.

Prof. (Dr.) Ajai Singh highlighted that this agreement signifies a new chapter in healthcare, combining the strengths of modern medical science with traditional Indian knowledge to deliver more effective, accessible, and holistic treatment options. He also announced that the Patanjali Research Foundation Trust will establish the largest herbal garden in Madhya Pradesh within the AIIMS Bhopal campus, providing a valuable resource for research and academic pursuits.

Dr. Anurag Varshney credited the blessings of Param Pujya Swami Ramdev Ji and the inspiration of Param Shraddhey Acharya Balkrishna Ji for driving this collaboration, which he described as a significant move toward positioning Patanjali Ayurveda on the global stage.

Prof. (Dr.) Ashok Kumar, a key organizer of the event, called the initiative a milestone in India’s journey toward self-reliance and empowerment in medicine, emphasizing that it exemplifies the successful integration of modernity and ancient wisdom.

Also present at the event were AIIMS Bhopal’s Dean (Research) Prof. (Dr.) Rehan-UI-Haq, Dean (Academics) Prof. (Dr.) Rajnish Joshi, Prof. (Dr.) Ashok Kumar, and several other senior officials and scientists.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices